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Salmonella and Campylobacter are recognized worldwide as the major foodborne pathogens 
responsible for human gastrointestinal diseases. The increased resistance of bacteria to 
antibiotics has encouraged the development of alternatives to control bacterial pathogens. 
Bacteriophages (phages), as natural predators of bacteria, are considered an appealing 
option. We report herein the isolation and genome characterisation of two Myoviridae broad 
lytic spectra Campylobacter (vB_CcoM-IBB35) and Salmonella phages (PVP-SE1) with high 
potential for therapy. The majority of genes of vB_CcoM-IBB35 are unique although 
homology exists with members of the Teequatrovirinae. Unique genes involved in 
pathogenesis, carbohydrate and amino acid metabolism were also observed along with 
several incidences of gene duplications, split genes with intein and introns and “insertion-like 
sequences”.  
From the 244 genes found in PVP-SE1, approximately 46% encode unique proteins and only 
22.1% exhibited homology with known proteins. The genome sequence presents high 
homology (145 gene encoding proteins) with the E.coli bacteriophage rV5, both unrelated to 
any other known phage, which might suggest that they belong to a new phage genetic group. 
As conclusion, one can argue that the genomic characterization of both phages did not 
reveal any factor which could preclude its therapeutic use.  
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